{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:52:58Z","timestamp":1790484778818,"version":"4.1.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"vor","delay-in-days":3237,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of nutrition, health and aging"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s12603-014-0515-3","type":"journal-article","created":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T12:41:19Z","timestamp":1412858479000},"page":"154-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Paths to Alzheimer's disease prevention: From modifiable risk factors to biomarker enrichment strategies"],"prefix":"10.1016","volume":"19","author":[{"given":"Simone","family":"Lista","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Hampel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s12603-014-0515-3_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","article-title":"The global prevalence of dementia: a systematic review and metaanalysis","volume":"9","author":"Prince","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s12603-014-0515-3_bib2","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","article-title":"Alzheimer's disease","volume":"377","author":"Ballard","year":"2011","journal-title":"Lancet"},{"key":"10.1007\/s12603-014-0515-3_bib3","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","article-title":"Global prevalence of dementia: a Delphi consensus study","volume":"366","author":"Ferri","year":"2005","journal-title":"Lancet"},{"key":"10.1007\/s12603-014-0515-3_bib4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.bcp.2014.01.003","article-title":"Future directions in Alzheimer's disease from risk factors to prevention","volume":"88","author":"Imtiaz","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1007\/s12603-014-0515-3_bib5","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1474-4422(10)70119-8","article-title":"Alzheimer's disease: clinical trials and drug development","volume":"9","author":"Mangialasche","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1007\/s12603-014-0515-3_bib6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jalz.2008.03.005","article-title":"A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium","volume":"4","author":"Khachaturian","year":"2008","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s12603-014-0515-3_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","article-title":"Amyloid precursor protein processing and Alzheimer's disease","volume":"34","author":"O'Brien","year":"2011","journal-title":"Annu Rev Neurosci"},{"key":"10.1007\/s12603-014-0515-3_bib8","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1021\/bi400209z","article-title":"Mechanistic studies unravel the complexity inherent in tau aggregation leading to Alzheimer's disease and the tauopathies","volume":"52","author":"Ramachandran","year":"2013","journal-title":"Biochemistry"},{"key":"10.1007\/s12603-014-0515-3_bib9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/039463201202500204","article-title":"Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease","volume":"25","author":"Verri","year":"2012","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1007\/s12603-014-0515-3_bib10","doi-asserted-by":"crossref","first-page":"13950","DOI":"10.1371\/journal.pone.0013950","article-title":"Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease","volume":"5","author":"Jones","year":"2010","journal-title":"PLoS One"},{"key":"10.1007\/s12603-014-0515-3_bib11","article-title":"Novel lipid signaling pathways in Alzheimer's disease pathogenesis","author":"Giannopoulos","year":"2013","journal-title":"Biochem Pharmacol."},{"key":"10.1007\/s12603-014-0515-3_bib12","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrn3012","article-title":"Linking lipids to Alzheimer's disease: cholesterol and beyond","volume":"12","author":"Di Paolo","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"10.1007\/s12603-014-0515-3_bib13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1017\/S1092852900014164","article-title":"The interplay of neurotransmitters in Alzheimer's disease","volume":"10","author":"Francis","year":"2005","journal-title":"CNS Spectr"},{"key":"10.1007\/s12603-014-0515-3_bib14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.tins.2008.10.003","article-title":"Deciphering complex mechanisms in neurodegenerative diseases: the advent of systems biology","volume":"32","author":"Noorbakhsh","year":"2009","journal-title":"Trends Neurosci"},{"key":"10.1007\/s12603-014-0515-3_bib15","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1038\/tp.2013.18","article-title":"Alterations in metabolic pathways and networks in Alzheimer's disease","volume":"3","author":"Kaddurah-Daouk","year":"2013","journal-title":"Transl Psychiatry"},{"issue":"4","key":"10.1007\/s12603-014-0515-3_bib16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.bcp.2013.11.009","article-title":"Perspective on Future Role of Biological Markers in Clinical Therapy Trials of Alzheimer's Disease: A Long-Range Point of View Beyond 2020","volume":"88","author":"Hampel","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1007\/s12603-014-0515-3_bib17","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.neurol.2013.07.016","article-title":"Alzheimer disease: from biomarkers to diagnosis","volume":"169","author":"Dubois","year":"2013","journal-title":"Rev Neurol (Paris)"},{"key":"10.1007\/s12603-014-0515-3_bib18","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jalz.2012.05.2116","article-title":"Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot","volume":"8","author":"Hampel","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s12603-014-0515-3_bib19","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nrneurol.2012.202","article-title":"Alzheimer disease: from inherited to sporadic AD-crossing the biomarker bridge","volume":"8","author":"Hampel","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"10.1007\/s12603-014-0515-3_bib20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.pneurobio.2011.09.011","article-title":"The role of genetics for biomarker development in neurodegeneration","volume":"95","author":"Bertram","year":"2011","journal-title":"Prog Neurobiol"},{"key":"10.1007\/s12603-014-0515-3_bib21","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1586\/erm.10.48","article-title":"Advances and perspectives from genetic research: development of biological markers in Alzheimer's disease","volume":"10","author":"Zetzsche","year":"2010","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1007\/s12603-014-0515-3_bib22","doi-asserted-by":"crossref","first-page":"S329","DOI":"10.3233\/JAD-2012-129030","article-title":"Perspectives for multimodal neurochemical and imaging biomarkers in Alzheimer's disease","volume":"33","author":"Teipel","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.1007\/s12603-014-0515-3_bib23","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.tins.2011.05.005","article-title":"Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia","volume":"34","author":"Ewers","year":"2012","journal-title":"Trends Neurosci"},{"key":"10.1007\/s12603-014-0515-3_bib24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.mcna.2012.12.013","article-title":"Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease","volume":"97","author":"Teipel","year":"2013","journal-title":"Med Clin North Am"},{"key":"10.1007\/s12603-014-0515-3_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"Blennow","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1007\/s12603-014-0515-3_bib26","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.expneurol.2009.09.024","article-title":"Biological markers of amyloid beta-related mechanisms in Alzheimer's disease","volume":"223","author":"Hampel","year":"2010","journal-title":"Exp Neurol"},{"key":"10.1007\/s12603-014-0515-3_bib27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exger.2009.10.010","article-title":"Total and phosphorylated tau protein as biological markers of Alzheimer's disease","volume":"45","author":"Hampel","year":"2010","journal-title":"Exp Gerontol"},{"key":"10.1007\/s12603-014-0515-3_bib28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jalz.2013.01.013","article-title":"The future of blood-based biomarkers for Alzheimer's disease","volume":"10","author":"Henriksen","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s12603-014-0515-3_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2012.06.007","article-title":"Blood and plasma-based proteomic biomarker research in Alzheimer's disease","volume":"101\u2013102","author":"Lista","year":"2013","journal-title":"Prog Neurobiol"},{"key":"10.1007\/s12603-014-0515-3_bib30","article-title":"CSF A\u03b21-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease","author":"Lista","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1007\/s12603-014-0515-3_bib31","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nrd3115","article-title":"Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives","volume":"9","author":"Hampel","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1007\/s12603-014-0515-3_bib32","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.pneurobio.2011.09.004","article-title":"Biomarkers in clinical trials for neurodegenerative diseases: regulatory perspectives and requirements","volume":"95","author":"Broich","year":"2011","journal-title":"Prog Neurobiol"},{"key":"10.1007\/s12603-014-0515-3_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.nic.2011.11.004","article-title":"Clinical and research diagnostic criteria for Alzheimer's disease","volume":"22","author":"Sarazin","year":"2012","journal-title":"Neuroimaging Clin N Am"},{"issue":"4","key":"10.1007\/s12603-014-0515-3_bib34","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jalz.2011.05.2243","article-title":"The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers","volume":"7","author":"Mattsson","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s12603-014-0515-3_bib35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jalz.2013.01.010","article-title":"CSF biomarker variability in the Alzheimer's Association quality control program","volume":"9","author":"Mattsson","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1007\/s12603-014-0515-3_bib36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/alzrt185","article-title":"Multiplex biomarkers in blood","volume":"5","author":"Gupta","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"10.1007\/s12603-014-0515-3_bib37","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1007\/s12603-014-0515-3_bib38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1007\/s12603-014-0515-3_bib39","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1007\/s12603-014-0515-3_bib40","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jalz.2010.03.008","article-title":"Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative","volume":"6","author":"Trojanowski","year":"2010","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s12603-014-0515-3_bib41","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.pneurobio.2011.07.004","article-title":"Neurodegenerative disease biomarkers: Guideposts for disease prevention through early diagnosis and intervention","volume":"95","author":"Trojanowski","year":"2011","journal-title":"Prog Neurobiol"},{"key":"10.1007\/s12603-014-0515-3_bib42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jalz.2012.04.007","article-title":"Worldwide Alzheimer's disease neuroimaging initiative","volume":"8","author":"Carrillo","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s12603-014-0515-3_bib43","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12603-013-0003-1","article-title":"Use of biomarkers and imaging to assess pathophysiology, mechanisms of action and target engagement","volume":"17","author":"Hampel","year":"2013","journal-title":"J Nutr Health Aging"},{"key":"10.1007\/s12603-014-0515-3_bib44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/npp.2013.154","article-title":"Biomarkers in amyloid-\u03b2 immunotherapy trials in Alzheimer's disease","volume":"39","author":"Blennow","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1007\/s12603-014-0515-3_bib45","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jalz.2013.03.007","article-title":"Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU\/US\/CTAD Task Force","volume":"9","author":"Vellas","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s12603-014-0515-3_bib46","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1586\/14737159.5.5.661","article-title":"CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment","volume":"5","author":"Blennow","year":"2005","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1007\/s12603-014-0515-3_bib47","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/alzrt104","article-title":"Dementia prevention: current epidemiological evidence and future perspective","volume":"4","author":"Mangialasche","year":"2012","journal-title":"Alzheimers Res Ther"},{"key":"10.1007\/s12603-014-0515-3_bib48","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/joim.12178","article-title":"Advances in the prevention of Alzheimer's disease and dementia","volume":"275","author":"Solomon","year":"2014","journal-title":"J Intern Med"},{"key":"10.1007\/s12603-014-0515-3_bib49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/B978-0-12-385883-2.00008-4","article-title":"The genetics of Alzheimer's disease","volume":"107","author":"Bertram","year":"2012","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1007\/s12603-014-0515-3_bib50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng1934","article-title":"Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database","volume":"39","author":"Bertram","year":"2007","journal-title":"Nat Genet"},{"issue":"7409","key":"10.1007\/s12603-014-0515-3_bib51","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature11283","article-title":"A mutation in APP protects against Alzheimer's disease and agerelated cognitive decline","volume":"488","author":"Jonsson","year":"2012","journal-title":"Nature"},{"key":"10.1007\/s12603-014-0515-3_bib52","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1532-5415.2012.04081.x","article-title":"Development of vascular risk factors over 15 years in relation to cognition: the Hoorn Study","volume":"60","author":"Reijmer","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"10.1007\/s12603-014-0515-3_bib53","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10654-013-9794-y","article-title":"Midlife cardiovascular risk factors and late cognitive impairment","volume":"28","author":"Virta","year":"2013","journal-title":"Eur J Epidemiol"},{"key":"10.1007\/s12603-014-0515-3_bib54","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/archneur.62.10.1556","article-title":"Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease","volume":"62","author":"Kivipelto","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1007\/s12603-014-0515-3_bib55","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/HYPERTENSIONAHA.111.178962","article-title":"Midlife blood pressure, plasma \u03b2-amyloid, and the risk for Alzheimer disease: the Honolulu Asia Aging Study","volume":"59","author":"Shah","year":"2012","journal-title":"Hypertension"},{"key":"10.1007\/s12603-014-0515-3_bib56","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/bmj.322.7300.1447","article-title":"Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study","volume":"322","author":"Kivipelto","year":"2001","journal-title":"BMJ"},{"key":"10.1007\/s12603-014-0515-3_bib57","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1212\/01.wnl.0000256368.57375.b7","article-title":"Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study","volume":"68","author":"Solomon","year":"2007","journal-title":"Neurology"},{"key":"10.1007\/s12603-014-0515-3_bib58","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.2337\/dc12-1287","article-title":"History of medically treated diabetes and risk of Alzheimer disease in a nationwide case-control study","volume":"36","author":"Tolppanen","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1007\/s12603-014-0515-3_bib59","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/epirev\/mxs012","article-title":"Type 2 Diabetes as a Risk Factor for Alzheimer's Disease: The Confounders, Interactions, and Neuropathology Associated With This Relationship","volume":"35","author":"Vagelatos","year":"2013","journal-title":"Epidemiol Rev"},{"key":"10.1007\/s12603-014-0515-3_bib60","doi-asserted-by":"crossref","first-page":"520","DOI":"10.2174\/156720511796391809","article-title":"Mediterranean diet in predementia and dementia syndromes","volume":"8","author":"Solfrizzi","year":"2011","journal-title":"Curr Alzheimer Res"},{"key":"10.1007\/s12603-014-0515-3_bib61","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1586\/ern.11.56","article-title":"Diet and Alzheimer's disease risk factors or prevention: the current evidence","volume":"11","author":"Solfrizzi","year":"2011","journal-title":"Expert Rev Neurother"},{"key":"10.1007\/s12603-014-0515-3_bib62","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3233\/JAD-130830","article-title":"Association of mediterranean diet with mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis","volume":"39","author":"Singh","year":"2014","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"10.1007\/s12603-014-0515-3_bib63","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1001\/jama.2009.1146","article-title":"Adherence to a Mediterranean diet, cognitive decline, and risk of dementia","volume":"302","author":"F\u00e9art","year":"2009","journal-title":"JAMA"},{"issue":"6","key":"10.1007\/s12603-014-0515-3_bib64","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jalz.2010.01.013","article-title":"Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline","volume":"6","author":"Yurko-Mauro","year":"2010","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s12603-014-0515-3_bib65","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/gps.3772","article-title":"Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective","volume":"27","author":"Panza","year":"2012","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1007\/s12603-014-0515-3_bib66","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000097995","article-title":"Alcohol drinking and cognitive functions: findings from the Cardiovascular Risk Factors Aging and Dementia (CAIDE) Study","volume":"23","author":"Ngandu","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1007\/s12603-014-0515-3_bib67","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/13607863.2012.742488","article-title":"The impact of alcohol on Alzheimer's disease: a systematic review","volume":"17","author":"Piazza-Gardner","year":"2013","journal-title":"Aging Ment Health"},{"key":"10.1007\/s12603-014-0515-3_bib68","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2741\/e367","article-title":"The nicotinic acetylcholine receptor: smoking and Alzheimer's disease revisited","volume":"4","author":"Mehta","year":"2012","journal-title":"Front Biosci (Elite Ed)"},{"key":"10.1007\/s12603-014-0515-3_bib69","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archinternmed.2010.393","article-title":"Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia","volume":"171","author":"Rusanen","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1007\/s12603-014-0515-3_bib70","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000320484","article-title":"Midlife smoking, apolipoprotein E and risk of dementia and Alzheimer's disease: a population-based cardiovascular risk factors, aging and dementia study","volume":"30","author":"Rusanen","year":"2010","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"12","key":"10.1007\/s12603-014-0515-3_bib71","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/gerona\/glq152","article-title":"The effect of midlife physical activity on cognitive function among older adults: AGES\u2014Reykjavik Study","volume":"65","author":"Chang","year":"2010","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"6","key":"10.1007\/s12603-014-0515-3_bib72","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1001\/jama.2009.1144","article-title":"Physical activity, diet, and risk of Alzheimer disease","volume":"302","author":"Scarmeas","year":"2009","journal-title":"JAMA"},{"key":"10.1007\/s12603-014-0515-3_bib73","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/JGP.0b013e3181eb00a9","article-title":"Physical activity and Alzheimer disease course","volume":"19","author":"Scarmeas","year":"2011","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1007\/s12603-014-0515-3_bib74","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1474-4422(05)70198-8","article-title":"Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease","volume":"4","author":"Rovio","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1007\/s12603-014-0515-3_bib75","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000353690","article-title":"Imaging and cognitive reserve studies predict dementia in presymptomatic Alzheimer's disease subjects","volume":"13","author":"Ferrari","year":"2014","journal-title":"Neurodegener Dis"},{"key":"10.1007\/s12603-014-0515-3_bib76","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.neurobiolaging.2011.10.003","article-title":"Education halves the risk of dementia due to apolipoprotein e4 allele: a collaborative study from the Swedish brain power initiative","volume":"33","author":"Wang","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1007\/s12603-014-0515-3_bib77","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00234-012-1005-0","article-title":"Education increases reserve against Alzheimer's disease\u2014evidence from structural MRI analysis","volume":"54","author":"Liu","year":"2012","journal-title":"Neuroradiology"},{"key":"10.1007\/s12603-014-0515-3_bib78","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nrneurol.2010.113","article-title":"Cognitive intervention in Alzheimer disease","volume":"6","author":"Buschert","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1007\/s12603-014-0515-3_bib79","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.4088\/JCP.11m07270","article-title":"Longterm observation of a multicomponent cognitive intervention in mild cognitive impairment","volume":"73","author":"Buschert","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"10.1007\/s12603-014-0515-3_bib80","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3233\/JAD-2011-100999","article-title":"Effects of a newly developed cognitive intervention in amnestic mild cognitive impairment and mild Alzheimer's disease: a pilot study","volume":"25","author":"Buschert","year":"2011","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"10.1007\/s12603-014-0515-3_bib81","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.60.5.753","article-title":"Depression as a risk factor for Alzheimer disease: the MIRAGE Study","volume":"60","author":"Green","year":"2003","journal-title":"Arch Neurol"},{"issue":"5","key":"10.1007\/s12603-014-0515-3_bib82","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.63.5.530","article-title":"Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis","volume":"63","author":"Ownby","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"10.1007\/s12603-014-0515-3_bib83","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3233\/JAD-2010-100390","article-title":"Depression and Alzheimer's disease: is stress the initiating factor in a common neuropathological cascade","volume":"23","author":"Aznar","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1007\/s12603-014-0515-3_bib84","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jns.2012.06.012","article-title":"Methodological challenges in designing dementia prevention trials \u2014 the European Dementia Prevention Initiative (EDPI)","volume":"322","author":"Richard","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.1007\/s12603-014-0515-3_bib85","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jalz.2012.09.012","article-title":"The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): study design and progress","volume":"9","author":"Kivipelto","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s12603-014-0515-3_bib86","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jalz.2009.01.008","article-title":"Commentary on \u2018A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.' The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's disease","volume":"5","author":"Gillette-Guyonnet","year":"2009","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s12603-014-0515-3_bib87","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/WAD.0b013e31819783a4","article-title":"Prevention of dementia by intensive vascular care (PreDIVA): a cluster-randomized trial in progress","volume":"23","author":"Richard","year":"2009","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1007\/s12603-014-0515-3_bib88","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jalz.2010.03.009","article-title":"Addressing population aging and Alzheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging Initiative","volume":"6","author":"Ellis","year":"2010","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s12603-014-0515-3_bib89","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3233\/JAD-2011-0059","article-title":"Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments","volume":"26","author":"Reiman","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1007\/s12603-014-0515-3_bib90","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/jama.1997.03540340027028","article-title":"Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation","volume":"277","author":"Lopera","year":"1997","journal-title":"JAMA"},{"key":"10.1007\/s12603-014-0515-3_bib91","doi-asserted-by":"crossref","first-page":"975","DOI":"10.4155\/cli.12.93","article-title":"Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network","volume":"2","author":"Morris","year":"2012","journal-title":"Clin Investig (Lond)"},{"key":"10.1007\/s12603-014-0515-3_bib92","doi-asserted-by":"crossref","first-page":"P425","DOI":"10.1016\/j.jalz.2012.05.1134","article-title":"The A4 trial: Anti-amyloid treatment of asymptomatic Alzheimer's disease","volume":"8","author":"Sperling","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s12603-014-0515-3_bib93","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jalz.2012.12.004","article-title":"Can we prevent Alzheimer's disease? Secondary \u201cprevention\u201d trials in Alzheimer's disease","volume":"9","author":"Carrillo","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s12603-014-0515-3_bib94","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archgenpsychiatry.2011.155","article-title":"Cerebrospinal fluid levels of beta-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia","volume":"69","author":"Buchhave","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.1007\/s12603-014-0515-3_bib95","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/archneurol.2011.183","article-title":"Evidence for ordering of Alzheimer disease biomarkers","volume":"68","author":"Jack","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1007\/s12603-014-0515-3_bib96","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1126\/scitranslmed.3002609","article-title":"Testing the right target and right drug at the right stage","volume":"3","author":"Sperling","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1007\/s12603-014-0515-3_bib97","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nrd3842-c1","article-title":"Moving towards early clinical trials for amyloidtargeted therapy in Alzheimer's disease","volume":"12","author":"Aisen","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1007\/s12603-014-0515-3_bib98","first-page":"2013","article-title":"The INSIGHT study: Conceptual considerations on the preclinical states of AD. OC34bis","volume":"14\u201316","author":"Dubois","year":"2013","journal-title":"Clinical Trials on Alzheimer's Disease (CTAD)"},{"key":"10.1007\/s12603-014-0515-3_bib99","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jalz.2009.01.022","article-title":"Prevent Alzheimer's disease by 2020: a national strategic goal","volume":"5","author":"Khachaturian","year":"2009","journal-title":"Alzheimers Dement"}],"container-title":["The Journal of nutrition, health and aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12603-014-0515-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12603-014-0515-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1279770723014112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1279770723014112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12603-014-0515-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:55:30Z","timestamp":1761137730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1279770723014112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":99,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1279770723014112"],"URL":"https:\/\/doi.org\/10.1007\/s12603-014-0515-3","relation":{},"ISSN":["1279-7707"],"issn-type":[{"value":"1279-7707","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paths to Alzheimer's disease prevention: From modifiable risk factors to biomarker enrichment strategies","name":"articletitle","label":"Article Title"},{"value":"The Journal of nutrition, health and aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12603-014-0515-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 SERDI Publisher.","name":"copyright","label":"Copyright"}]}}